
CNL Healthcare Properties, Inc. is a Maryland corporation that incorporated on June 8, 2010. We elected to be taxed as a REIT for U.S. federal income tax purposes beginning with the year ended December 31, 2012 and our intention is to be organized and operate in a manner that allows us to remain qualified as a REIT for federal income tax purposes.
CNL Healthcare Properties, Inc. trades as CHTH on OTC. The company is classified in Real Estate / REIT - Healthcare Facilities and reports in USD.
The current profile places the business in REIT - Healthcare Facilities. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.
Latest available fiscal data shows $392.65M of revenue and -$8.81M of net income.
Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.
The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.
CNL Healthcare Properties, Inc. can be compared against peers such as Activia Properties Inc., First Real Estate Investment Trust, G City Ltd, K. Wah International Holdings Limited, Helios Re Socimi, S.a., Nexity S.A..
A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.
Current signals to investigate include market capitalization of $930.70M, beta of 0.69, and return on equity of -1.3%.
This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.
Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.
CHTH currently shows total debt of $0 and beta of 0.69. Missing data should be treated as a research gap, not as low risk.
Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.
No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.
Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.
Recent filings to review: 4 (2026-03-11 00:00:00), 4 (2026-03-11 00:00:00), 15-12G (2026-03-11 00:00:00), S-3DPOS (2026-03-11 00:00:00).
Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.
Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.
Company website: https://www.cnlhealthcareproperties.com
For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.